Birchview Capital, LP - AVEO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$397,000
+75.7%
120,000
+20.0%
0.26%
+66.2%
Q2 2018$226,000
-22.1%
100,0000.0%0.15%
-19.4%
Q1 2018$290,000100,0000.19%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders